Authors' Reply: Pharmacokinetic Issue May Influence the Perceived Cardiac Risk Posed by Ondansetron in Patients Undergoing Chronic Hemodialysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Authors' Reply: Pharmacokinetic Issue May Influence the Perceived Cardiac Risk Posed by Ondansetron in Patients Undergoing Chronic Hemodialysis

Published:2024-05-20 Issue:8 Volume:35 Page:1136-1136
ISSN:1046-6673
Container-title:Journal of the American Society of Nephrology
language:en
Short-container-title:JASN

Author:

Ismail Sherin¹^ORCID,Funk Michele Jonsson¹^ORCID,Flythe Jennifer E.²³^ORCID

Affiliation:

1. Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina (UNC) at Chapel Hill, Chapel Hill, North Carolina

2. UNC Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, UNC School of Medicine, Chapel Hill, North Carolina

3. Cecil G. Sheps Center for Health Services Research, University of North Carolina (UNC) at Chapel Hill, Chapel Hill, North Carolina

Funder

NHLBI Division of Intramural Research

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference3 articles.

1. Pharmacokinetic issue may influence the perceived cardiac risk posed by ondansetron in patients undergoing chronic hemodialysis;Hung;J Am Soc Nephrol.,2024

2. Ondansetron and the risk of sudden cardiac death among individuals receiving maintenance hemodialysis;Ismail;J Am Soc Nephrol.,2024

3. Proton pump inhibitors may enhance the risk of citalopram- and escitalopram-associated sudden cardiac death among patients receiving hemodialysis;Assimon;Pharmacoepidemiol Drug Saf.,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP